Merck's immunotherapy, chemo mix shows extended lung cancer gains
MADRID (Reuters) - Giving Merck& Co's immunotherapy drug Keytruda in combination with chemotherapy for previously untreated advanced lung cancer appears to provide durable benefits, according to an update of a closely watched clinical trial.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Health | Immunotherapy | Lung Cancer | Merck